| Spirig HealthCare AG - Levetiracetam Spirig HC 100 mg/ml, Lösung zum Einnehmen | | 69095 | | 01 | | Levetiracetam Spirig HC 100 mg/ml | | Lösung zum Einnehmen | | N03AX14 | | Levetiracetam | | 14.12.2023 | | |
| | Composition | | levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum, E 218 2.5 mg, glycerolum, acesulfamum kalicum, maltitolum liquidum 300 mg, aromatica (Himbeere) cum alcohol benzylicus 0.0016 mg et propylenglycolum, aqua purificata, ad solutionem pro 1 ml corresp. natrium 0.99 mg. | | Packungsbestandteile | | Lösung (oral) | | | | | | | | Active Agent | Dose |
|---|
| Levetiracetamum | 100 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Levetiracetamum | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acesulfamum Kalicum | | | | Acidum Citricum | | | | Aqua Purificata | | | | Aromatica (Himbeere) cum Alcohol Benzylicus | 0.0016 mg/ml | | | E 218 | 2.5 mg/ml | conserv. | | Glycerolum | | | | Maltitolum Liquidum | 300 mg/ml | | | Natrii Citras Dihydricus | | | | Propylenglycolum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 300 ml | 44.50 | 64.95 | B | SL | No |
|
|
